Not applicableStudy completedNCT03563183What this trial is testingAssess Frailty of Subjects During ZOSTER-006 and ZOSTER-022Who this might be right forHerpes Zoster GlaxoSmithKline 26,976
Large-scale testing (Phase 3)Study completedNCT04176939What this trial is testingTest GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune ResponseWho this might be right forHerpes Zoster GlaxoSmithKline 68
Large-scale testing (Phase 3)Study completedNCT01165177What this trial is testingStudy to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and OlderWho this might be right forHerpes Zoster GlaxoSmithKline 16,165
Large-scale testing (Phase 3)Study completedNCT01254630What this trial is testingEvaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)Who this might be right forHerpes Zoster Merck Sharp & Dohme LLC 5,305
Large-scale testing (Phase 3)Study completedNCT01767467What this trial is testingStudy to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood CancersWho this might be right forHerpes Zoster GlaxoSmithKline 568
Post-approval studies (Phase 4)Enrolling By InvitationNCT06763783What this trial is testingVaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic DiseasesWho this might be right forSystemic VasculitisSpondylarthropathiesPsoriatic Arthritis+6 more Region Skane 240
Early research (Phase 1)Looking for participantsNCT06874842What this trial is testingSafety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and OlderWho this might be right forHerpes Zoster (HZ) Guangzhou Patronus Biotech Co., Ltd. 92
Not applicableActive Not RecruitingNCT06638177What this trial is testingObesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic NeuralgiaWho this might be right forHerpes Zoster (HZ) Brigham and Women's Hospital 200,000
Large-scale testing (Phase 3)Study completedNCT01165229What this trial is testingStudy to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and OlderWho this might be right forHerpes ZosterHerpes Zoster Vaccine GlaxoSmithKline 14,819
Large-scale testing (Phase 3)Study completedNCT02723773What this trial is testingA Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older AdultsWho this might be right forHerpes ZosterHerpes Zoster Vaccine GlaxoSmithKline 7,539
Large-scale testing (Phase 3)Study completedNCT02581410What this trial is testingImmunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years EarlierWho this might be right forHerpes Zoster GlaxoSmithKline 430
Testing effectiveness (Phase 2)Study completedNCT00492648What this trial is testingMonth 30 & 42 Extension Studies of CRD-004 Primary StudyWho this might be right forHerpes Zoster GlaxoSmithKline 34
Large-scale testing (Phase 3)Study completedNCT01798056What this trial is testingImmunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving ChemotherapyWho this might be right forHerpes ZosterHerpes Zoster Vaccine GlaxoSmithKline 237
Early research (Phase 1)Study completedNCT05871541What this trial is testingA First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster VaccineWho this might be right forHerpes Zoster (HZ)ShinglesInfectious Disease Immorna Biotherapeutics, Inc. 75
Testing effectiveness (Phase 2)Looking for participantsNCT06978192What this trial is testingClinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High VoltageWho this might be right forHerpes Zoster (HZ) Fenghui Deng 92
Large-scale testing (Phase 3)Study completedNCT02979639What this trial is testingStudy to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of AgeWho this might be right forHerpes Zoster GlaxoSmithKline 404
Large-scale testing (Phase 3)Study completedNCT02052596What this trial is testingStudy to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and OlderWho this might be right forHerpes Zoster GlaxoSmithKline 935
Early research (Phase 1)Ended earlyNCT05701800What this trial is testingEvaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of AgeWho this might be right forHerpes Zoster ModernaTX, Inc. 659
Not applicableLooking for participantsNCT06903078What this trial is testingA Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.Who this might be right forHerpes Zoster (HZ)Vascular Dementia Center for Clinical Studies, Texas 375
Large-scale testing (Phase 3)Study completedNCT02690207What this trial is testingCross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.Who this might be right forHerpes Zoster GlaxoSmithKline 8,687